Vitreous surgery for idiopathic macular holes stage 2 and 3. Results and prognostic factors;Prognostische faktoren und resultate nach operativer behandlung idiopathischer macula foramina stadium 2 und 3

Klinische Monatsblatter fur Augenheilkunde

Volumn 216, Issue 5, 2000, Pages 272-277

  Gander, Irène Ch ^a   Senn, Peter ^a   Lüthi, Magdalena ^a   Schipper, Isaak ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Macula hole; Visual field; Vitreous surgery

Indexed keywords

ADULT; AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; EPIRETINAL MEMBRANE; FEMALE; HUMAN; LENS IMPLANT; MALE; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETINA MACULA HOLE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD DEFECT; VITRECTOMY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LASER COAGULATION; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PATIENT SATISFACTION; PHACOEMULSIFICATION; QUESTIONNAIRES; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; SWITZERLAND; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS; VITRECTOMY;

EID: 0034043331     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-10559     Document Type: Article

References (63)

1. Aaberg TM, Blair CJ, Gass JDM. Macular holes. Am J Ophthalmol 1970; 69: 555-562.
2. Alving BM, Weinstein MJ, Finlayson JS, Menitove JE, Fratantoni JL. Fibrin sealant: summary of a conference on characteristics and clinical uses.Transfusion 1995; 35: 783-790.
3. Apple DJ, Federmann JL, Krolicki TJ, et al. Irreversible silicone oil adhesion to silicone intraocular lenses. Ophthalmology 1996; 103: 1555-1561.
4. Bach M, Kommerell G. Sehschärfebestimmung nach Europäischer Norm: wissenschaftliche Grundlagen und Möglichkeiten der automatischen Messung. Klin Monatsbl Augenheilkd 1998; 212: 190-195.
5. Banker AS, Freemann WR, Kim JW, Munguia D, Azen SP. Vision threatening complications of surgery for full-thickness macular holes. The vitrectomy for macular hole study group. Ophthalmology 1997; 104: 1442-1453.
6. Bartz-Schmidt KU, Konen W, Esser P, Walter P, Heimann K. Intraokulare Silikonlinsen und Silikonöl. Klin Monatsbl Augenheilkd 1995; 207: 162-166.
7. Boldt HC, Munden PM, Folk JC, Mehaffey MG. Visual defect after macular hole surgery. Am J Ophthalmol 1996; 122: 371-381.
8. Bopp S, Lucke K, Hille U. Peripheral visual field loss after vitreous surgery for macular holes. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 362-371.
9. Bronstein MA, Trempe CL, Freemann HM. Fellow eyes with macular holes. Am J Ophthalm 1981; 92: 757-761.
10. Chang TS, McGill E, Hay DA, Ross WH, Maberley AL, Sibley LM, Ma PE, Potter MJ. Prophylactic scleral buckle for prevention of retinal detachment following vitrectomy for macular hole. Br J Ophthalmol 1999; 83: 944-948.
11. Christmas NJ, Smiddy WE, Flynn HW. Reopening of macular holes after initially successful repair. Ophthalmology 1998; 105: 1835-38.
12. Coats G. The pathology of macular holes. Roy London Hosp Rep 1907; 17: 69-96.
13. De Bustros S. Early stages of macular hole: To treat or not to treat (edit.). Arch Ophthalmol 1990; 108: 1085-1086.
14. De Bustros S. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. The vitrectomy for prevention of macular hole study group. Ophthalmology 1994; 101: 1055-1059.
15. Duker JS, Wendel R, Patel AC, Puliafito CA. Late re-opening of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 1994; 101: 1373-1378.
16. Eaton AM, Jaffe GJ, McCuen BW, Mincey GJ. Condensation on the posterior surface of silicone intraocular lenses during fluid-air exchange. Ophthalmology 1995; 102: 733-736.
17. Ezra E, Arden GB, Riordan-Eva P, Aylward GW, Gregor ZJ. Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol 1996; 80: 519-525.
18. Fuchs E. Zur Veränderung der macula lutea nach Contusion. Ztschr Augenheilk 1901; 6: 181-186.
19. Gass JD. Idiopathic senile macular hole: Its early stages and pathogenesis. Arch Ophthalmology 1988; 106: 629-639.
20. Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995; 119: 752-759.
21. Gaudric A, Massin P, Paques M. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995; 233: 549-554.
22. Gaudric A, Paques M, Massin P. Use of autologous platelet concentrate in full-thickness macular hole surgery: results of a multicenter, double-blind randomized trial. Presented at the annual meeting of the American Academy of ophthalmology, San Francisco, CA 1997; 27: 143.
23. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA. Transforming growth factor-beta 2 for the treatment of full thickness macular holes: A prospective randomized study. Ophthalmology 1992; 99: 1162-1172.
24. Goldbaum MH, McCuen BW, Hanneken AM, Burgess SK, Chen HH. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 1998; 105 (11): 2140-2148.
25. Heier JS, Topping TM, Frederick AR, Morley MG, Millay R, Pesavento RD. Visual and surgical outcomes of retinal detachment following macular hole repair. Retina 1999; 19: 110-115.
26. Hikichi T, Akiba J, Trempe CL. Effekt of the vitreous on the prognosis of full-thickness idiopathic macular hole. Am J Ophthalmol 1993; 116: 273-278.
27. Hikichi T, Yoshida A, Akiba J, Trempe CL. Natural outcomes of stage 1,2,3 and 4 idiopathic macular holes. Br J Ophthalmol 1995; 79: 517-520.
28. Hutton WL, Fuller DG, Snyder WB, Fellman RL, Swanson WH. Visual field defects after macular hole surgery. Ophthalmology 1996; 103: 2152-2159.
29. Ikuno Y, Kamei M, Saito Y, Ohji M, Tano Y. Photocoagulation and fluid-gas exchange to treat persistent macular holes after prior vitrectomy. Ophthalmology 1998; 105: 1411-1418.
30. Johnson RN, Gass JD. Idiopathic macular holes: Observations, stages of formation and implications for surgical intervention. Ophthalmology 1988; 95: 917-924.
31. Kasaka S, Kodoma T, Ohashi Y. Condensation of silicone oil on the posterior surface of a silicone intraocular lens during vitrectomy. Am J Ophthalmol 1996; 121: 574-575.
32. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: Results of a pilot study. Arch Ophthalmol 1991; 109: 654-659.
33. Kerrison JB, Haller JA, Elman M, Miller NR. Visual field loss following vitreous surgery. Arch Ophthalmol 1996; 114: 564-569.
34. Kim JW, Freeman WR, Azen SP, El-Haig W, Klein DJ, Bailey IL. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. The vitrectomy for prevention of macular hole study group. Am J Ophthalmol 1996; 121: 605-614.
35. Kim JW, Freeman WR, El-Haig W, Maguire AM, Arevalo JF, Azen SP. Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. The vitrectomy for prevention of macular hole study group. Ophthalmology 1995; 102: 1818-1829.
36. Korobelnik JF, Hannouche D, Belayachi N, Branger M, Guez JE, Hoang-Xuan T. Autologous platelet concentrate as an adjunct in macular hole healing. Ophthalmology 1996; 103: 590-594.
37. Lansing MB, Glaser BM, Liss H, Hanham A, Thompson JT, Sjaarda RN, Gordon AJ. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full thickness macular holes. Ophthalmology 1993; 100: 868-871.
38. Leonard ER, Smiddy WE, Flynn HW, Fever W. Long-term visual outcomes in patients with successful macular hole surgery. Ophthalmology 1997; 104: 1648-1652.
39. McDonnell PJ, Fine SL, Hillis AI. Clinical features of idiopathic macular cysts and holes. Am J Ophthalmol 1982; 93: 777-786.
40. Melberg NS, Thomas MA. Visual field loss after pars plana vitrectomy with air/fluid exchange. Am J Ophthalmol 1995; 120: 386-388.
41. Miller JH, Googe JM, Hoskins JC. Combined macular hole and cataract surgery. Am J Ophthalmol 1997; 123: 705-707.
42. Noyes HD. Detachment of the retina with laceration at the macula lutea. Trans Am Ophthalmol Soc 1871; 1: 128-129.
43. Ohji M, Nao-I N, Saito Y, Hayashi A, Tano Y. Prevention of field defect after macular hole surgery by passing air used for fluid-air exchange through water. Am J Ophthalmol 1999; 127: 62-66.
44. Orella J, Liebermann RM. Stage III macular hole surgery. Br J Ophthalmol 1993; 77: 555-558.
45. Paques M, Massin P, Santiago PY, Spielmann AC, Gaudric A. Visual field loss after vitrectomy for full-thickness macular holes. Am J Ophthalmol 1997; 124: 88-94.
46. Park SS, Marcus DM, Duker JS, Pesavento RD, Topping TM, Frederick AR, D'Amico DJ. Posterior segment complications after vitrectomy for Macular hole. Ophthalmology 1995; 102: 775-781.
47. Pendergast SD, McCuen II BW. Visual field loss after macular hole surgery. Ophthalmology 1996; 103: 1069-1077.
48. Roth DB, Smiddy WE, Feuer W. Vitreous surgery for chronic macular holes. Ophthalmology 1997; 104: 2047-2052.
49. Ruby AJ, Williams DF, Grand MG, Thomas MA, Meredith TA, Boniuk I, Olk RJ. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994; 112: 359-364.
50. Ryan EH Jr, Gilbert HD. Results of surgical treatment of recent-oncet full thickness idiopathic macular holes. Arch Ophthal 1994; 112: 1545-1553.
51. Senn P, Schmid MK, Schipper I, Hendrickson P. Interaction Between Silicone Oil and Silicone Intraocular Lenses: An In Vitro Study. Ophthalmic Surg and Lasers 1997; 28, 9: 776-779.
52. Sjaarda RN, Frank DA, Glaser BM, Thompson JT, Murphy RP. Resolution of an absolute scotoma and improvement of relative scotoma after successful macular hole surgery. Am J Ophthalmol 1993; 116: 129-139.
53. Smiddy WE, Glaser BM, Thompson JT, Sjaarda RN, Flynn HW, Hanham A, Murphy RP. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes: Preliminary anatomic results of a multicenter prospective randomized study. Retina 1993; 13: 296-301.
54. Smiddy WE, Michels RG, Glaser BM, de Bustros S. Vitrectomy for impending idiopathic macular holes. Am J Ophthalmol 1988; 105: 371-376.
55. Smiddy WE, Sjaarda RN, Glaser BM, Flynn HW, Thompson JT, Hanham A, Murphy RP. Reoperation after failed macular hole surgery. Retina 1996; 16: 13-18.
56. Stolba U, Binder S, Velikay M, Wedrich A. Intraocular silicone lenses in silicone oil: an experimental study. Graefes Arch Clin Exp Ophthalmol 1996; 234: 55-57.
57. The eye disease case-control study group. Rise factors for idiopathic macular hole. Am J Ophthalmology 1994; 118: 754-761.
58. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994; 101: 1195-1200.
59. Thompson JT, Smiddy WE, Williams GA, Sjaarda RN, Flynn HW, Margherio RR, Abrams GW. Comparison of recombinant transforming growth factor-beta 2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 1998; 105: 700-706.
60. Trempe CL, Weiler JJ, Furukawa H. Fellow eyes in cases of macular hole. Arch Ophthalmol 1986; 104: 93-95.
61. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. Ophthalmology 1993; 100: 1671-1676.
62. Willis AW, Garcia-Cosia JF. Macular hole surgery: comparison of longstanding versus recent macular holes. Ophthalmology 1996; 103: 1811-1814.
63. Yan H, Dhurjon L, Glas G, Chow DR, Williams D, Chen JC. Visual field defect after pars plana vitrectomy. Ophthalmology 1998; 105: 1612-1616.